ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,962, issued on Sept. 23, was assigned to BioTheryX Inc. (San Diego).
"Quinazolines, pharmaceutical compositions, and therapeutic applications" was invented by Paul E. Erdman (San Diego), Leah M. Fung (San Diego), Patrick Papa (Carlsbad, Calif.) and Brandon W. Whitefield (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are quinazolines, e.g., a compound of Formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of an SOS1-mediated disorder, disease, or condition."
The patent was filed on March 15, 2023, under Applicati...